IL36RN and pustular psoriasis: Patients with GPP carrying loss-of-function (LoF) mutations in IL36RN (encoding IL-36 receptor antagonist) or heterozygous mutations in AP1S3 (resulting in increased IL-36α expression) were described, suggesting a pivotal role of IL-36 cytokine activity in driving pustular psoriasis (27–31).